NEUROMEDICA, a clearinghouse for information concerning
the organic chemistry, design, and pharmacology of psychedelics and related compounds.
[ HOME | INTRODUCTION | CHEMISTRY | PHARMACOLOGY | PEOPLE | LINKS ]
Dr. Richard A. Glennon, PhD.
Bibliography:
Dukat M, 1996
Structure-activity relationships for the binding of arylpiperazines and
arylbiguanides at 5-HT3 serotonin receptors.
J. Med. Chem. 39, 4017-4026 (1996)
Young R, 1996
A three-lever operant procedure differentiates the stimulus effects of
R(-)-MDA from S(+)-MDA.
J. Pharmacol. Exp. Ther. 276, 594-601 (1996)
Glennon RA, 1996
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta
receptors.
J. Med. Chem. 39, 314-322 (1996)
Glennon RA, 1996
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant
receptors may involve formation of two hydrogen bonds to asparagine.
Mol. Pharmacol. 49, 198-206 (1996)
Glennon RA, 1995
Methcathione ("cat"): an enantiomeric potency comparison.
Pharmacol. Biochem. Behav. 50, 601-606 (1995)
Ismaiel AM, 1995
Ketanserin analogues: the effect of structural modification on 5-HT2
serotonin receptor binding.
J. Med. Chem. 38, 1196-1202 (1995)
Choudhary MS, 1995
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A
receptors: ergolines require an aromatic residue at position 340 for
high affinity binding.
Mol. Pharmacol. 47, 450-457 (1995)
Glennon RA, 1994
5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin
receptor agonist.
J. Med. Chem. 37, 2828-2830 (1994)
Glennon RA, 1994
Influence of amine substituents on 5-HT2A versus 5-HT2C binding of
phenylalkyl- and indolylalkylamines.
J. Med. Chem. 37, 1929-1935 (1994)
Glennon RA, 1994
Structural features important for sigma 1 receptor binding.
J. Med. Chem. 37, 1214-1219 (1994)
Westkaemper RB, 1994
Molecular modeling of the interaction of LSD and other hallucinogens
with 5-HT2 receptors.
NIDA Res. Monogr. 146, 263-283 (1994)
Glennon RA, 1994
Classical hallucinogens: an introductory overview.
NIDA Res. Monogr. 146, 4-32 (1994)
Damaj MI, 1994
Involvement of the serotonergic system in the hypoactive and
antinociceptive effects of nicotine in mice.
Brain Res. Bull. 33, 199-203 (1994)
Glennon RA, 1993
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl
homolog of DOM.
Pharmacol. Biochem. Behav. 46, 459-462 (1993)
Ismaiel AM, 1993
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus
with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
J. Med. Chem. 36, 2519-2525 (1993)
Glennon RA, 1993
Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several
structurally related analogs.
Pharmacol. Biochem. Behav. 45, 865-869 (1993)
Young R, 1993
Cocaine-stimulus generalization to two new designer drugs:
methcathinone and 4-methylaminorex.
Pharmacol. Biochem. Behav. 45, 229-231 (1993)
Herndon JL, 1992
Ketanserin analogues: structure-affinity relationships for 5-HT2 and
5-HT1C serotonin receptor binding.
J. Med. Chem. 35, 4903-4910 (1992)
Glennon RA, 1992
Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane
as a discriminative stimulus: antagonism by 5-hydroxytryptamine3
antagonists.
Pharmacol. Biochem. Behav. 43, 1099-1106 (1992)
Glennon RA, 1992
Investigation of MDMA-related agents in rats trained to discriminate
MDMA from saline.
Pharmacol. Biochem. Behav. 43, 759-763 (1992)
Herndon JL, 1992
Mechanistic investigation of the stimulus properties of
1-(3-trifluoromethylphenyl)piperazine.
Pharmacol. Biochem. Behav. 43, 739-748 (1992)
Darmani NA, 1992
Behavioral evidence for differential adaptation of the serotonergic
system after acute and chronic treatment with (+/-
)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
J. Pharmacol. Exp. Ther. 262, 692-698 (1992)
Darmani NA, 1992
Repeated administration of low doses of cocaine enhances the
sensitivity of 5-HT2 receptor function.
Pharmacol. Biochem. Behav. 41, 519-527 (1992)
Young R, 1992
Zacopride and its optical isomers produce stereoselective antagonism of
a 2-methylserotonin discriminative stimulus.
Eur. J. Pharmacol. 212, 117-119 (1992)
Glennon RA, 1992
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin
receptors: evidence for a lack of selectivity.
J. Med. Chem. 35, 734-740 (1992)
Glennon RA, 1992
5-HT3 agonist 2-methylserotonin as a training drug in discrimination
studies.
Pharmacol. Biochem. Behav. 41, 361-364 (1992)
Glennon RA, 1992
Hallucinogens and serotonergic mechanisms.
NIDA Res. Monogr. 119, 131-135 (1992)
Westkaemper RB, 1991
Approaches to molecular modeling studies and specific application to
serotonin ligands and receptors.
Pharmacol. Biochem. Behav. 40, 1019-1031 (1991)
Glennon RA, 1991
Serotonin receptors and their ligands: a lack of selective agents.
Pharmacol. Biochem. Behav. 40, 1009-1017 (1991)
Glennon RA, 1991
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as
high-affinity sigma ligands.
J. Med. Chem. 34, 3360-3365 (1991)
Raghupathi RK, 1991
Analogues of the 5-HT1A serotonin antagonist
1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced
alpha 1-adrenergic affinity.
J. Med. Chem. 34, 2633-2638 (1991)
Glennon RA, 1991
Binding of substituted and conformationally restricted derivatives of
N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptors.
J. Med. Chem. 34, 1855-1859 (1991)
Glennon RA, 1991
Serotonin receptors and site-selective agents.
J Physiol Pharmacol 42, 49-60 (1991)
Glennon RA, 1991
Identification and exploitation of the sigma-opiate pharmacophore.
J. Med. Chem. 34, 1094-1098 (1991)
Darmani NA, 1991
Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine
via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A
receptors.
Pharmacol. Biochem. Behav. 38, 353-357 (1991)
Glennon RA, 1991
Multiple populations of serotonin receptors may modulate the behavioral
effects of serotonergic agents.
Life Sci. 48, 2493-2498 (1991)
Glennon RA, 1991
Phenylalkylamine stimulants, hallucinogens, and designer drugs.
NIDA Res. Monogr. 105, 154-160 (1991)
Glennon RA, 1991
Discriminative stimulus properties of hallucinogens and related
designer drugs.
NIDA Res. Monogr. 116, 25-44 (1991)
Glennon RA, 1990
Stimulus properties of tiflucarbine: a novel antidepressant agent.
Pharmacol. Biochem. Behav. 37, 769-771 (1990)
Higgs RA, 1990
Stimulus properties of ring-methyl amphetamine analogs.
Pharmacol. Biochem. Behav. 37, 835-837 (1990)
Rydelek-Fitzgerald L, 1990
NAN-190: agonist and antagonist interactions with brain 5-HT1A
receptors.
Brain Res. 532, 191-196 (1990)
Appel NM, 1990
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I]
iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c
receptors in rat brain.
J. Pharmacol. Exp. Ther. 255, 843-857 (1990)
Glennon RA, 1990
(-)PPAP: a new and selective ligand for sigma binding sites.
Pharmacol. Biochem. Behav. 37, 557-559 (1990)
Glennon RA, 1990
Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination
of a hydrophobic binding region.
J. Med. Chem. 33, 2777-2784 (1990)
Glennon RA, 1990
Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Neuropsychopharmacology 3, 509-517 (1990)
Yousif MY, 1990
Identification of metabolites of 3,4-methylenedioxymethamphetamine in
rats.
Drug Alcohol Depend 26, 127-135 (1990)
Darmani NA, 1990
Withdrawal from chronic treatment with (+/-)-DOI causes
super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in
mice.
Eur. J. Pharmacol. 186, 115-118 (1990)
Darmani NA, 1990
Pharmacological characterization of ear-scratch response in mice as a
behavioral model for selective 5-HT2-receptor agonists and evidence for
5-HT1B- and 5-HT2-receptor interactions.
Pharmacol. Biochem. Behav. 37, 95-99 (1990)
Darmani NA, 1990
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Pharmacol. Biochem. Behav. 36, 901-906 (1990)
Seggel MR, 1990
A structure-affinity study of the binding of 4-substituted analogues of
1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
J. Med. Chem. 33, 1032-1036 (1990)
Glennon RA, 1990
Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
Pharmacol. Biochem. Behav. 35, 517-521 (1990)
Ismaiel AM, 1990
5-HT1 and 5-HT2 binding profiles of the serotonergic agents
alpha-methylserotonin and 2-methylserotonin.
J. Med. Chem. 33, 755-758 (1990)
Glennon RA, 1990
Serotonin receptors: clinical implications.
Neurosci Biobehav Rev 14, 35-47 (1990)
Teitler M, 1990
Receptor pharmacology of MDMA and related hallucinogens.
Ann. N. Y. Acad. Sci. 600, 626-638 (1990)
Glennon RA, 1989
Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a
structure-affinity study.
Eur. J. Pharmacol. 168, 387-392 (1989)
Glennon RA, 1989
N-(phthalimidoalkyl) derivatives of serotonergic agents: a common
interaction at 5-HT1A serotonin binding sites?
J. Med. Chem. 32, 1921-1926 (1989)
Glennon RA, 1989
Stimulus effects of
N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and
N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in
rats trained to discriminate MDMA from saline.
Pharmacol. Biochem. Behav. 33, 909-912 (1989)
Fitzgerald RL, 1989
Determination of 3,4-methylenedioxyamphetamine and
3,4-methylenedioxymethamphetamine enantiomers in whole blood.
J. Chromatogr. 490, 59-69 (1989)
Pierson ME, 1989
Design and synthesis of propranolol analogues as serotonergic agents
J. Med. Chem. 32, 859-863 (1989)
Glennon RA, 1989
Stimulus properties of hallucinogenic phenalkylamines and related
designer drugs: formulation of structure-activity relationships.
NIDA Res. Monogr. 94, 43-67 (1989)
Fitzgerald RL, 1989
Stereochemistry of the metabolism of MDMA to MDA.
Life Sci. 45, 295-301 (1989)
Naiman N, 1989
2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin
binding sites.
J. Med. Chem. 32, 253-256 (1989)
Sadzot B, 1989
Hallucinogenic drug interactions at human brain 5-HT2 receptors:
implications for treating LSD-induced hallucinogenesis.
Psychopharmacology (Berl.) 98, 495-499 (1989)
Glennon RA, 1988
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
J. Med. Chem. 31, 1968-1971 (1988)
Glennon RA, 1988
NAN-190: an arylpiperazine analog that antagonizes the stimulus effects
of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin
(8-OH-DPAT).
Eur. J. Pharmacol. 154, 339-341 (1988)
Glennon RA, 1988
A preliminary behavioral investigation of PMMA, the 4-methoxy analog of
methamphetamine.
Pharmacol. Biochem. Behav. 31, 9-13 (1988)
Glennon RA, 1988
A preliminary investigation of the psychoactive agent
4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
Pharmacol. Biochem. Behav. 30, 597-601 (1988)
Glennon RA, 1988
N,N-di-n-propylserotonin: binding at serotonin binding sites and a
comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
J. Med. Chem. 31, 867-870 (1988)
Glennon RA, 1988
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane
(MDA) analogs.
Pharmacol. Biochem. Behav. 29, 443-449 (1988)
Lyon RA, 1988
Indolealkylamine analogs share 5-HT2 binding characteristics with
phenylalkylamine hallucinogens.
Eur. J. Pharmacol. 145, 291-297 (1988)
Glennon RA, 1988
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated
radioligand that specifically labels the agonist high-affinity state of
5-HT2 serotonin receptors.
J. Med. Chem. 31, 5-7 (1988)
Glennon RA, 1988
Site-selective serotonin agonists as discriminative stimuli.
Psychopharmacol Ser 4, 15-31 (1988)
Titeler M, 1988
Radioligand binding evidence implicates the brain 5-HT2 receptor as a
site of action for LSD and phenylisopropylamine hallucinogens.
Psychopharmacology (Berl.) 94, 213-216 (1988)
Glennon RA, 1988
Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine
(TFMPP) to propranolol, pindolol, and mesulergine.
Pharmacol. Biochem. Behav. 29, 197-199 (1988)
Titeler M, 1987
Selectivity of serotonergic drugs for multiple brain serotonin
receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine
([3H]DOB), a 5-HT2 agonist radioligand.
Biochem. Pharmacol. 36, 3265-3271 (1987)
Rosecrans JA, 1987
The effect of MDA and MDMA ("Ecstasy") isomers in combination with
pirenpirone on operant responding in mice.
Pharmacol. Biochem. Behav. 28, 39-42 (1987)
Seggel MR, 1987
Effect of 5-HT2-selective agonists on cat platelet aggregation.
Life Sci. 41, 1077-1081 (1987)
Glennon RA, 1987
N-methyl derivatives of the 5-HT2 agonist
1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
J. Med. Chem. 30, 930-932 (1987)
Glennon RA, 1987
Methcathinone: a new and potent amphetamine-like agent.
Pharmacol. Biochem. Behav. 26, 547-551 (1987)
Glennon RA, 1987
The effect of MDMA ("Ecstasy") and its optical isomers on
schedule-controlled responding in mice.
Pharmacol. Biochem. Behav. 26, 425-426 (1987)
Glennon RA, 1987
Central serotonin receptors as targets for drug research.
J. Med. Chem. 30, 1-12 (1987)
Young R, 1987
Stimulus properties of benzodiazepines: correlations with binding
affinities, therapeutic potency, and structure activity relationships
(SAR).
Psychopharmacology (Berl.) 93, 529-533 (1987)
Young R, 1987
Effects of pyrazolopyridines and a triazolopyridazine on the
pentobarbital discriminative stimulus.
Psychopharmacology (Berl.) 93, 494-497 (1987)
Rasmussen K, 1986
Phenethylamine hallucinogens in the locus coeruleus: potency of action
correlates with rank order of 5-HT2 binding affinity.
Eur. J. Pharmacol. 132, 79-82 (1986)
Young R, 1986
Further studies on the dose-dependent stimulus properties of
5-methoxy-N,N-dimethyltryptamine.
Pharmacol. Biochem. Behav. 25, 1207-1210 (1986)
Glennon RA, 1986
5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.
J. Med. Chem. 29, 2375-2380 (1986)
Kalix P, 1986
Further evidence for an amphetamine-like mechanism of action of the
alkaloid cathinone.
Biochem. Pharmacol. 35, 3015-3019 (1986)
Glennon RA, 1986
Discriminative stimulus properties of the serotonergic agent
1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Life Sci. 39, 825-830 (1986)
Young R, 1986
Potencies of diazepam metabolites in rats trained to discriminate
diazepam.
Life Sci. 39, 17-20 (1986)
Glennon RA, 1986
Discriminative stimulus properties of the 5-HT1A agonist
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
Pharmacol. Biochem. Behav. 25, 135-139 (1986)
Glennon RA, 1986
Discriminative stimulus properties of phenylisopropylamine derivatives.
Drug Alcohol Depend 17, 119-134 (1986)
Lyon RA, 1986
Synthesis and evaluation of phenyl- and benzoylpiperazines as potential
serotonergic agents.
J. Med. Chem. 29, 630-634 (1986)
Glennon RA, 1986
5-HT1 and 5-HT2 binding characteristics of
1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.
J. Med. Chem. 29, 194-199 (1986)
McKenney JD, 1986
TFMPP may produce its stimulus effects via a 5-HT1B mechanism.
Pharmacol. Biochem. Behav. 24, 43-47 (1986)
Arvidsson LE, 1986
Recent advances in central 5-hydroxytryptamine receptor agonists and
antagonists.
Prog Drug Res 30, 365-471 (1986)
Young R, 1986
Discriminative stimulus properties of amphetamine and structurally
related phenalkylamines.
Med Res Rev 6, 99-130 (1986)
Glennon RA, 1986
Structure-activity relationships and mechanism of action of
hallucinogenic agents based on drug discrimination and radioligand
binding studies.
Psychopharmacol Bull 22, 953-958 (1986)
Lyon RA, 1986
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions
at brain 5-HT1 and 5-HT2 receptors.
Psychopharmacology (Berl.) 88, 525-526 (1986)
Glennon RA, 1985
Mechanistic studies on DOM as a discriminative stimulus.
Pharmacol. Biochem. Behav. 23, 937-941 (1985)
Titeler M, 1985
[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Eur. J. Pharmacol. 117, 145-146 (1985)
Schechter MD, 1985
Cathinone, cocaine and methamphetamine: similarity of behavioral
effects.
Pharmacol. Biochem. Behav. 22, 913-916 (1985)
Glennon RA, 1985
Structure-activity studies on methoxy-substituted phenylisopropylamines
using drug discrimination methodology.
Pharmacol. Biochem. Behav. 22, 723-729 (1985)
Glennon RA, 1984
Evidence for 5-HT2 involvement in the mechanism of action of
hallucinogenic agents.
Life Sci. 35, 2505-2511 (1984)
Glennon RA, 1984
Structure-activity studies on amphetamine analogs using drug
discrimination methodology.
Pharmacol. Biochem. Behav. 21, 895-901 (1984)
Glennon RA, 1984
Discriminative stimulus properties of the serotonin agonist
1-(3-trifluoromethylphenyl)piperazine (TFMPP).
Life Sci. 35, 1475-1480 (1984)
Glennon RA, 1984
Mesoionic xanthine analogues: antagonists of adenosine receptors.
J. Med. Chem. 27, 1364-1367 (1984)
Glennon RA, 1984
Discriminative stimulus properties of S(-)- and R(+)-cathinone,
(+)-cathine and several structural modifications.
Pharmacol. Biochem. Behav. 21, 1-3 (1984)
Shannon M, 1984
5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen
1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).
Eur. J. Pharmacol. 102, 23-29 (1984)
Young R, 1984
Stereoselective stimulus effects of 3-methylflunitrazepam and
pentobarbital.
Life Sci. 34, 1977-1983 (1984)
Wood PL, 1984
Unique [3H]tryptamine binding sites in rat brain: distribution and
pharmacology.
Arch Int Pharmacodyn Ther 268, 194-201 (1984)
Aceto MD, 1984
Similarity between (+)-amphetamine and amfonelic acid.
Pharmacol. Biochem. Behav. 20, 635-637 (1984)
Glennon RA, 1984
Further investigation of the discriminative stimulus properties of MDA.
Pharmacol. Biochem. Behav. 20, 501-505 (1984)
Glennon RA, 1984
MDA: an agent that produces stimulus effects similar to those of
3,4-DMA, LSD and cocaine.
Eur. J. Pharmacol. 99, 249-250 (1984)
Schechter MD, 1984
Comparison of behavioral effects of cathinone, amphetamine and
apomorphine.
Pharmacol. Biochem. Behav. 20, 181-184 (1984)
Glennon RA, 1984
MDA: a psychoactive agent with dual stimulus effects.
Life Sci. 34, 379-383 (1984)
Glennon RA, 1984
Synthesis and evaluation of a novel series of
N,N-dimethylisotryptamines.
J. Med. Chem. 27, 41-45 (1984)
Glennon RA, 1984
1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary
investigation.
Gen Pharmacol 15, 361-362 (1984)
Glennon RA, 1983
Antagonism of the effects of the hallucinogen DOM and the purported
5-HT agonist quipazine by 5-HT2 antagonists.
Eur. J. Pharmacol. 91, 189-196 (1983)
Glennon RA, 1983
Drug-induced discrimination: a description of the paradigm and a review
of its specific application to the study of hallucinogenic agents.
Med Res Rev 3, 289-340 (1983)
Glennon RA, 1983
A comparison of the behavioral properties of (+/-)-, (-)-, and
(+)-5-methoxy-alpha-methyltryptamine.
Biol. Psychiatry 18, 493-498 (1983)
Glennon RA, 1983
Indolealkylamine and phenalkylamine hallucinogens. Effect of
alpha-methyl and N-methyl substituents on behavioral activity.
Biochem. Pharmacol. 32, 1267-1273 (1983)
Glennon RA, 1983
DOM-stimulus generalization to LSD and other hallucinogenic
indolealkylamines.
Eur. J. Pharmacol. 86, 453-459 (1983)
Young R, 1983
Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and
dose-dependent antagonism by BC-105.
Psychopharmacology (Berl.) 80, 156-160 (1983)
Lund MQ, 1982
Preliminary studies of mesoionic 3-(substituted-aryl)-psi-oxatriazoles
as potential antihypertensive agents.
J. Med. Chem. 25, 1503-1505 (1982)
Kline TB, 1982
Structure-activity relationships for hallucinogenic
N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor
affinities of methylthio and methylenedioxy derivatives.
J. Med. Chem. 25, 1381-1383 (1982)
Glennon RA, 1982
Behavioral and serotonin receptor properties of 4-substituted
derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
J. Med. Chem. 25, 1163-1168 (1982)
Glennon RA, 1982
Comparison of behavioral properties of di- and
tri-methoxyphenylisopropylamines.
Pharmacol. Biochem. Behav. 17, 603-607 (1982)
Glennon RA, 1982
Discriminative stimulus properties of MDA analogs.
Biol. Psychiatry 17, 807-814 (1982)
Young R, 1982
Comparative discriminative stimulus effects of
5-methoxy-N,N-dimethyltryptamine and LSD.
Life Sci. 30, 2057-2062 (1982)
Glennon RA, 1982
A comparison of the behavioral effects of DOM homologs.
Pharmacol. Biochem. Behav. 16, 557-559 (1982)
Glennon RA, 1982
Discriminative stimulus properties of DOM and several molecular
modifications.
Pharmacol. Biochem. Behav. 16, 553-556 (1982)
Glennon RA, 1982
Serotonin receptor affinity of cathinone and related analogues.
J. Med. Chem. 25, 393-397 (1982)
Glennon RA, 1982
Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and
5-OMe DMT with their methythio counterparts.
Life Sci. 30, 465-467 (1982)
Glennon RA, 1982
2,3-dihydro and carbocyclic analogues of tryptamines: interaction with
serotonin receptors.
J. Med. Chem. 25, 68-70 (1982)
Glennon RA, 1982
Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
Neurosci Biobehav Rev 6, 489-497 (1982)
Glennon RA, 1981
Behavioral properties of psychoactive phenylisopropylamines in rats.
Eur. J. Pharmacol. 76, 353-360 (1981)
Domelsmith LN, 1981
Photoelectron spectra of psychotropic drugs. 6. Relationships between
the physical properties and pharmacological actions of amphetamine
analogues.
J. Med. Chem. 24, 1414-1421 (1981)
Rogers ME, 1981
Mesoionic purinone analogues as inhibitors of cyclic-AMP
phosphodiesterase: a comparison of several ring systems.
J. Med. Chem. 24, 1284-1287 (1981)
Glennon RA, 1981
Serotonin receptor interactions of harmaline and several related
beta-carbolines.
Life Sci. 29, 861-865 (1981)
Glennon RA, 1981
Synthesis and evaluation of novel alkylpiperazines as potential
dopamine antagonists.
J. Med. Chem. 24, 678-683 (1981)
Glennon RA, 1981
Benz-fused mesoionic xanthine analogues as inhibitors of cyclic-AMP
phosphodiesterase.
J. Med. Chem. 24, 766-769 (1981)
Glennon RA, 1981
Mesoionic xanthine analogues: phosphodiesterase inhibitory and
hypotensive activity.
J. Med. Chem. 24, 658-661 (1981)
Glennon RA, 1981
DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral
and serotonin receptor properties.
Pharmacol. Biochem. Behav. 14, 287-292 (1981)
Glennon RA, 1981
Speculations on the mechanism of action of hallucinogenic
indolealkylamines.
Neurosci Biobehav Rev 5, 197-207 (1981)
Glennon RA, 1980
Studies on several 7-substituted N,N-dimethyltryptamines.
J. Med. Chem. 23, 1222-1226 (1980)
Glennon RA, 1980
Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis
and serotonin receptor affinities.
J. Med. Chem. 23, 990-994 (1980)
Glennon RA, 1980
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
J. Med. Chem. 23, 294-299 (1980)
Young R, 1980
Discriminative stimulus properties of the hallucinogenic agent DOM.
Commun Psychopharmacol 4, 501-506 (1980)
Glennon RA, 1980
Hallucinogenic agents as discriminative stimuli: a correlation with
serotonin receptor affinities.
Psychopharmacology (Berl.) 68, 155-158 (1980)
Rosecrans JA, 1979
Drug-induced cues in studying mechanisms of drug action.
Neuropharmacology 18, 981-989 (1979)
Glennon RA, 1979
Bufotenine esters.
J. Med. Chem. 22, 1414-1416 (1979)
Glennon RA, 1979
Molecular connectivity analysis of hallucinogenic mescaline analogs.
J Pharm Sci 68, 906-907 (1979)
Glennon RA, 1979
The effect of chirality on serotonin receptor affinity.
Life Sci. 24, 1487-1492 (1979)
Glennon RA, 1979
Serotonin receptor binding affinities of tryptamine analogues.
J. Med. Chem. 22, 428-432 (1979)
Glennon RA, 1979
Hallucinogens as a discriminative stimuli: generalization of DOM to a
5-methoxy-N, N-dimethyltryptamine stimulus.
Life Sci. 24, 993-997 (1979)
Glennon RA, 1978
Mesoionic xanthine analogs as inhibitors of cyclic AMP
phosphodiesterase.
J Pharm Sci 67, 1762-1765 (1978)
Glennon RA, 1978
Serotonin receptor binding affinities of several hallucinogenic
phenylalkylamine and N,N-dimethyltryptamine analogues.
J. Med. Chem. 21, 822-825 (1978)
Kier LB, 1978
Psychotomimetic phenalkylamines as serotonin agonists: an SAR analysis.
Life Sci. 22, 1589-1593 (1978)
Glennon RA, 1978
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal
serotonin uptake.
Res Commun Chem Pathol Pharmacol 19, 161-164 (1978)
Kier LB, 1978
Progress with several models for the study of the SAR of hallucinogenic
agents.
NIDA Res. Monogr. 22, 159-185 (1978)
Glennon RA, 1977
The electronic and serotonin receptor binding affinity properties of
N,N-dimethyltryptamine analogs.
Res Commun Chem Pathol Pharmacol 18, 453-465 (1977)
Glennon RA, 1974
A quantum chemical investigation of the pi-electronic structure of the
hallucinogenic N,N-dimethyltryptamines.
Res Commun Chem Pathol Pharmacol 9, 185-188 (1974)
Coburn RA, 1974
Mesoionic purinone analogs. 7. In vitro antibacterial activity of
mesoionic 1,3,4-thiadiazolo(3,2-a)pyrimidine-5,7-diones.
J. Med. Chem. 17, 1025-1027 (1974)
Coburn RA, 1973
Mesoionic purinone analogs. IV. Synthesis and in vitro antibacterial
properties of mesoionic thiazolo(3,2-a)pyrimidin-5,7-diones and
mesoionic 1,3,4-thiadizolo(3,2-a)pyrimidin-5,7-diones.
J Pharm Sci 62, 1785-1789 (1973)
[ HOME | INTRODUCTION | CHEMISTRY | PHARMACOLOGY | PEOPLE | LINKS ]
Created and maintained by paracelsus, with the cooperation of the Lycaeum.
Last updated on March 4, 1997.